Gentronix recognised with King’s award after record international growth

UK-based Contract Research Organisation (CRO) Gentronix – a leading specialist toxicology firm based at Alderley Park – has been awarded the King’s Award for Enterprise after achieving a triple-figure revenue growth following rapid expansion in international markets. Gentronix recorded total growth of 239% in overseas earnings over the past three years, with the percentage of

Why we invested: IsomAb

Earlier this year, we participated in a £7.5m seed round into IsomAb, a UK-based biotechnology company developing a novel treatment for a common cardiovascular condition. The links between heart health and lifestyle are well known but deaths from cardiovascular diseases continue to rise. In fact, one such disease, atherosclerosis, has now surpassed communicable diseases to

Biomanufacturing: What good looks like for an investor

The transition towards biomanufacturing, and the move away from traditional, energy-intensive processes in industry is creating unprecedented opportunities for start-ups. Understanding the investor’s perspective in this space can help founders prepare more effectively for their fundraise. Below is a snippet of some of the most critical aspects we and other investors look for at the

Year end trading summary and date of full year result

Mercia Asset Management PLC is pleased to provide a trading summary for the financial year ended 31 March 2024. Organic fund inflows for FY24 as a whole exceeded £0.5billion, which is a record for Mercia and represents a c.40% increase in Mercia’s third-party funds under management, since the beginning of the financial year. There were

Mercia Ventures – The exciting field of Digital Biology

Eric Horvitz, the Chief Scientific Officer at Microsoft, recently said: “We’re in the early days of a revolutionary era of digital biology rising at the convergence of biology and computer science. Advances at the intersection will fundamentally change our understandings about the mysteries of biology, with extraordinary implications for health, medicine, and sustainability.” Such strong

Mercia completes syndicated funding rounds into three existing direct investments

Mercia Asset Management PLC is pleased to confirm it has recently completed syndicated funding rounds into three of its existing direct investments. The investments comprised: £1.2million as part of an £7.1million syndicated funding round into MIP Discovery Limited. MIP is an innovative developer of non-biological affinity reagents designed to accelerate the development and production of

Why we invested: Graide

Since Mercia Ventures first invested in Graide in 2022, a lot has changed in the world of artificial intelligence. With the rise of ChatGPT and other LLMs, AI is rapidly becoming part of everyday life. Through its unique approach, Graide is bringing this transformative innovation to the education market. In December 2023, almost two years

Webinar | Tax year end planning with EIS and VCT

Join Dr Paul Mattick as he demonstrates, with case studies, on how to plan your taxes in the run up to tax year end with EIS and VCT. This is technical tax planning webinar, which may be very relevant to your clients. *𝗣𝗹𝗲𝗮𝘀𝗲 𝗿𝗲𝗮𝗱 𝘁𝗵𝗲 𝗳𝘂𝗹𝗹 𝗿𝗶𝘀𝗸 𝘄𝗮𝗿𝗻𝗶𝗻𝗴𝘀* Visit Mercia’s EIS area

Webinar | Mercia’s Knowledge-intensive (KI) EIS fund

Stefan Helm discusses Mercia’s Knowledge-Intensive (KI) EIS fund. Mercia’s KI EIS Fund can be used to reduce income tax paid in 2022/2023, and due to our rapid deployment, the tax reliefs will be available during 2024. This is technical tax planning webinar hosted by Stefan, which may be very relevant to your clients in the